Position in VIR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,050,576
+$847,012 QoQ
Shares Held
593,776
+2.2% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 237 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. VIR ranks #11 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in VIR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,050,576 | 593,776 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $5,203,564 | 580,755 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,676,647 | 609,726 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $4,080,142 | 714,561 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $3,550,059 | 704,377 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $906,162 | 139,840 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,001,813 | 136,487 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $3,168,920 | 423,087 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,452,261 | 275,535 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,387,276 | 235,664 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,493,648 | 148,474 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,416,378 | 151,161 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,745,166 | 152,677 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $3,473,326 | 149,262 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $3,900,144 | 154,095 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,958,708 | 153,460 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $3,922,838 | 154,018 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,897,480 | 151,535 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $6,239,676 | 149,025 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $404,866 | 9,303 | Shares | Sole | 2021-11-01 | |
| No filing history on record for this holder in this stock. | ||||||